glycolipid replacement therapy (Seneb Biosciences)

N/A

Report date: 2025/06/11 11:22:24
NME

Base Information

Drug Nameglycolipid replacement therapy (Seneb Biosciences)
Drug Alias Nameglycolipids (Seneb)SNB-4050SNB-2401
ClassificationSmall molecules > Carbohydrate > Oligosaccharide
Mechanisms of ActionNeuroprotectants
TargetsUpdating
Therapy Area/IndicationsHyperinsulinismNeuronal Ceroid-LipofuscinosesParkinson Disease +[4] 
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesNeose Technologies
China Registration ClassN/A

Develop Information

Active CompaniesSeneb BioSciences Inc
Inactive CompaniesNeose Technologies
Active IndicationsHyperinsulinismNeuronal Ceroid-LipofuscinosesParkinson Disease +[4] 
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A